Shangya Technology Co., Ltd. (TPEX:6130)
Taiwan · Delayed Price · Currency is TWD 24.70
-2.25 (-8.35%)
Apr 1, 2026, 1:30 PM CST
Shangya Technology Market Cap
Shangya Technology has a market cap or net worth of 1.19 billion as of April 1, 2026. Its market cap has increased by 20.58% in one year.
Market Cap
1.19B
Enterprise Value
1.28B
Revenue
154.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.70
Market Cap Chart
Since November 3, 2004, Shangya Technology's market cap has increased from 885.72M to 1.19B, an increase of 34.79%. That is a compound annual growth rate of 1.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 1.19B | -39.44% |
| Dec 31, 2025 | 1.97B | 88.96% |
| Dec 31, 2024 | 1.04B | -31.54% |
| Dec 29, 2023 | 1.52B | 15.05% |
| Dec 30, 2022 | 1.32B | -7.53% |
| Dec 30, 2021 | 1.43B | 117.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 222.70B |
| Caliway Biopharmaceuticals | 134.02B |
| Bora Pharmaceuticals | 55.75B |
| Lotus Pharmaceutical | 54.40B |
| Great Novel Therapeutics Biotech & Medicals | 1.28B |
| Excelsior Biopharma | 1.26B |
| DV Biomed | 1.24B |
| Meribank Biotech | 1.20B |